Ketan Patel has worked in healthcare for over 13 years, as an investor, consultant, and physician. Prior to joining F-Prime (formerly Fidelity Biosciences) in 2007, Dr. Patel was an engagement manager in the corporate consulting division of Leerink Swann & Company. While at Leerink, he advised biopharmaceutical and medical device companies on brand strategy, clinical development plans, and business development activities. Dr. Patel served as a physician at the VA Boston Healthcare System and at Weill Cornell Medical Center-New York Presbyterian Hospital and Memorial-Sloan Kettering Cancer Center where he completed his internal medicine training.
Dr. Patel focuses on investing in therapeutics and medical device companies and has served as a director or board observer of Aclaris Therapeutics, Acorn Cardiovascular, Amphora Medical, Bioconnect Systems, Ivenix, Laurus Labs, NextWave Pharmaceuticals, Trivitron Healthcare, Vicept Therapeutics, and Xcyton Diagnostics.
Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution’s Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University.